With China's recent announcement of robust stimulus measures, the Hong Kong market has seen a significant uplift, reflecting renewed investor confidence. This positive sentiment provides an opportune moment to explore dividend stocks on the SEHK that can offer steady income streams amidst the current economic backdrop. When considering dividend stocks, it's essential to look for companies with strong fundamentals and a consistent track record of payouts, especially in times of economic stimulation.
Overview: China Xinhua Education Group Limited, with a market cap of HK$1.16 billion, offers higher and secondary vocational education services in the People's Republic of China.
Operations: China Xinhua Education Group Limited generated CN¥647.30 million from its education services segment.
Dividend Yield: 8.8%
China Xinhua Education Group reported CNY 213.12 million in net income for the half year ended June 30, 2024, up from CNY 181.45 million a year ago. Despite its attractive dividend yield (8.82%), the company's dividend payments have been volatile and unreliable over the past five years. However, dividends are well covered by earnings (27.2% payout ratio) and cash flows (24.8% cash payout ratio), indicating strong financial sustainability despite an unstable track record in payouts.
Overview: Sinofert Holdings Limited is an investment holding company involved in the production, import and export, distribution, and retail of fertilizer raw materials and crop nutrition products in Mainland China and internationally, with a market cap of HK$8.22 billion.
Operations: Sinofert Holdings Limited generates revenue from its Production segment (CN¥5.15 billion), Basic Business segment (CN¥13.93 billion), and Growth Business segment (CN¥11.14 billion).
Dividend Yield: 4.2%
Sinofert Holdings reported half-year sales of CNY 13.68 billion and net income of CNY 1.05 billion, showing slight growth from the previous year. The company's dividend payments are well covered by earnings (46.5% payout ratio) and cash flows (14.9% cash payout ratio). However, its dividend history has been volatile over the past decade, making it less reliable despite recent improvements in financial performance and a relatively low dividend yield compared to top-tier payers in Hong Kong.
Overview: Beijing Tong Ren Tang Chinese Medicine Company Limited, with a market cap of HK$7.71 billion, manufactures, retails, and wholesales healthcare products and Chinese medicine to both wholesalers and individuals.
Operations: Beijing Tong Ren Tang Chinese Medicine Company Limited generates revenue from three primary segments: Overseas (HK$429.03 million), Hong Kong (HK$979.91 million), and Mainland China (HK$240.56 million).
Dividend Yield: 3.6%
Beijing Tong Ren Tang Chinese Medicine's dividend yield of 3.58% is lower than the top 25% of dividend payers in Hong Kong. While dividends have been stable and growing over the past decade, they are not well covered by free cash flows or earnings. Recent half-year results showed a decline in sales to HK$664.52 million and net income to HK$219.78 million, indicating potential challenges ahead for maintaining current dividend levels without sufficient earnings support.
Click this link to deep-dive into the 82 companies within our Top SEHK Dividend Stocks screener.
Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SEHK:2779 SEHK:297 and SEHK:3613.
